Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs
  • CALCIUM GLUCONATE FOR INJECTION
  • Magnesium chloride hexahydrate
  • Dinātrija-1-glicerofosfāta pentahidrāts
  • Valid
Authorised in these countries:
  • Bulgaria
Export to PDF

Product identification

Medicine name:
Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs
Калтетан форте, 458,4 mg/ml + 125 mg/ml + 20 mg/ml инфузионен разтвор за коне
Active substance and strength:
  • CALCIUM GLUCONATE FOR INJECTION
    458.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dinātrija-1-glicerofosfāta pentahidrāts
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Authorisation number:
  • 0022-3110
Product identification number:
  • e6c72c0c-7e91-4ca3-a324-f66e3938784b
Permanent identification number:
  • 600000092613

Product details

Legal status of supply:
This information is not available for this product.
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Milk
        5
        week
    • Cattle
      • Meat and offal
        5
        week
    • Pig
      • Meat and offal
        5
        week

Availability

Package description:
  • Polypropylene (PP) bottles closed with a bromobutyl rubber stopper, type I and secured with an aluminium cap. Package size: 500 ml
Manufacturing sites for batch release:
  • Vet-Agro Sp. z o.o.
  • Vet-Agro Sp. z o.o.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • PL/V/0110/002
Date of authorisation status change:
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Authorisation country:
  • Bulgaria
Responsible authority:
  • BFSA
Marketing authorisation holder:
  • Vet-Agro Sp. z o.o.
Marketing authorisation issued:
Reference member state:
  • Poland
Concerned member states:
  • Bulgaria
  • Czechia
  • Greece
  • Hungary
  • Italy
  • Lithuania
  • Portugal
  • Romania
  • Spain
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

Summary of Product Characteristics (PDF)
First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."